Small cap Cellmid develops innovative cancer therapies and diagnostic tests and has the most comprehensive portfolio of intellectual property in its specialist areas.
Due to a company rebranding, Cellmid appointed Interactive Investor to develop and create a corporate site. The website’s objective was to allow Cellmid to directly communicate with stakeholders, but it also needed to attract prospective investors.
Interactive Investor created a user-friendly interface so users could find the desired information quickly and efficiently. Brand consistency was also ensured. The site also featured a privacy section for people to register interest in the company and access confidential documents once approved. This allowed Cellmid to capture contact details and accumulate a database of prospective investors. The Cellmid website also integrated Interactive Investor’s ASX Automated Responder™, ensuring the latest company announcements – including share-price information – appear on Cellmid’s IR site.
The new website exceeded expectations with its user-friendly interface and incorporation of the Interactive Roadshow eKit™, giving viewers access to videos, interactive online reports, media releases and analyst reports. Personal engagement was also ensured, with the Cellmid CEO able to answer prospective investor enquiries through video and slideshows.